Trials / Terminated
TerminatedNCT04143841
Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease
A Pilot Study to Evaluate the Safety and Effectiveness of the Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Epitech Mag Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and effectiveness of Viveye OMNS non-invasive treatment for management of the signs and symptoms of severe dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Viveye OMNS treatment | The Viveye OMNS treatment ( \~30 min) will be applied once, during the treatment visit only |
| DEVICE | Viveye OMNS sham treatment | The Viveye OMNS sham treatment ( \~30 min) will be applied once, during the treatment visit only |
Timeline
- Start date
- 2019-10-30
- Primary completion
- 2021-01-06
- Completion
- 2021-01-06
- First posted
- 2019-10-29
- Last updated
- 2021-04-21
Locations
3 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT04143841. Inclusion in this directory is not an endorsement.